Taste test may identify best drugs for depression

December 6, 2006
Taste test may identify best drugs for depression

New research has shown that it might be possible to use taste as an indicator as to whether someone is depressed, and as a way of determining which is the most suitable drug to treat their depression.

Research from the University of Bristol has shown that our ability to recognise certain tastes can be improved by administering drugs usually given for depression.

The researchers gave healthy volunteers antidepressant drugs that increase levels of the neurotransmitters serotonin and noradrenaline. They report today in the Journal of Neuroscience that these tests resulted in the volunteers being able to detect different tastes (salt, sugar, sour, and bitter) at lower concentrations, thus enhancing their ability to taste.

Dr Lucy Donaldson, senior author on the paper, said: "When we increased serotonin levels we found that people could recognise sweet and bitter taste at much lower concentrations than when their serotonin levels were normal. With increased noradrenaline levels the same people could recognise bitter and sour tastes at lower concentrations. Salt taste doesn't seem to be affected at all by altering either of these neurotransmitters."

She added: "Because we have found that different tastes change in response to changes in the two different neurotransmitters, we hope that using a taste test in depressed people will tell us which neurotransmitter is affected in their illness."

Dr Jan Melichar, the lead psychiatrist on the paper, added: "This is very exciting. Until now we have had no easy way of deciding which is the best medication for depression. As a result, we get it right about 60-80% of the time. It then takes up to four weeks to see if the drug is working, or if we need to change it. However, with a taste test, we may be able to get it right first time."

Taste is often thought to be determined genetically and, until now, people assumed it was fixed throughout life. But these studies show that the ability to recognise different tastes can be altered by the neurotransmitters serotonin and noradrenaline and by people's mood.

In the study, three drugs were given to the volunteers: SSRI (serotonin specific reuptake inhibitor) to raise serotonin levels; NARI (noradrenaline reuptake inhibitor) to raise noradrenaline levels (another neurotransmitter important in depression, and also found in taste buds); and an inactive placebo.

The volunteers were first tested for their ability to recognise certain tastes. The drug was then administered and two hours afterwards they were asked to take the same test again.

The volunteers were also assessed for anxiety levels, their overall level of anxiety being related to their ability to taste; the more anxious a person was, the less sensitive to bitter and salt taste they were.

These results give an important insight into how neurotransmitters affect the taste system. It seems that tasting bitter things can be changed by changes in both serotonin and noradrenaline levels, that sweet taste is affected by only serotonin levels, and that sour taste is affected by noradrenaline.

These findings may also explain why anxious and depressed individuals have diminished appetite. The results also show that taste is related to anxiety levels, even in generally well people.

Source: University of Bristol

Explore further: Why losing weight is hard – but not impossible

Related Stories

Why losing weight is hard – but not impossible

October 10, 2014

Seeing pictures of preened celebrities, or even slimmer friends, makes many wish that their arms were that little bit thinner or abs more tightly toned. Most of us have an existing desire to be a normal healthy weight, but ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.